Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Levine MZ, Holiday C, Bai Y, Zhong W, Liu F, Jefferson S, Gross FL, Tzeng WP, Fries L, Smith G, Boutet P, Friel D, Innis BL, Mallett CP, Davis CT, Wentworth DE, York IA, Stevens J, Katz JM, Tumpey T. Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population Immunity. Vaccines (Basel). 2022 Nov 1;10(11). doi: 10.3390/vaccines10111856. PubMed PMID: 36366364; PubMed Central PMCID: PMC9694415.
Lu X, Guo Z, Li ZN, Holiday C, Liu F, Jefferson S, Gross FL, Tzeng WP, Kumar A, York IA, Uyeki TM, Tumpey T, Stevens J, Levine MZ. Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection. Sci Rep. 2022 Sep 2;12(1):14971. doi: 10.1038/s41598-022-18977-0. PubMed PMID: 36056075; PubMed Central PMCID: PMC9440095.
Alymova IV, Cipollo JF, Parsons LM, Music N, Kamal RP, Tzeng WP, Goldsmith CS, Contessa JN, Hartshorn KL, Wilson JR, Zeng H, Gansebom S, York IA. Aberrant Cellular Glycosylation May Increase the Ability of Influenza Viruses to Escape Host Immune Responses through Modification of the Viral Glycome. mBio. 2022 Apr 26;13(2):e0298321. doi: 10.1128/mbio.02983-21. Epub 2022 Mar 14. PubMed PMID: 35285699; PubMed Central PMCID: PMC9040841.
Patel MM, York IA, Monto AS, Thompson MG, Fry AM. Immune-mediated attenuation of influenza illness after infection: opportunities and challenges. Lancet Microbe. 2021 Dec;2(12):e715-e725. doi: 10.1016/S2666-5247(21)00180-4. Epub 2021 Sep 24. Review. PubMed PMID: 35544110.
Music N, Tzeng WP, Liaini Gross F, Levine MZ, Xu X, Shieh WJ, Tumpey TM, Katz JM, York IA. Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets. NPJ Vaccines. 2019;4:28. doi: 10.1038/s41541-019-0123-7. eCollection 2019. PubMed PMID: 31312528; PubMed Central PMCID: PMC6616337.
York IA, Stevens J, Alymova IV. Influenza virus N-linked glycosylation and innate immunity. Biosci Rep. 2019 Jan 31;39(1). doi: 10.1042/BSR20171505. Print 2019 Jan 31. Review. PubMed PMID: 30552137; PubMed Central PMCID: PMC6328934.
Sayedahmed EE, Kumari R, Shukla S, Hassan AO, Mohammed SI, York IA, Gangappa S, Sambhara S, Mittal SK. Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy. Vaccine. 2018 Oct 29;36(45):6744-6751. doi: 10.1016/j.vaccine.2018.09.031. Epub 2018 Sep 25. PubMed PMID: 30266488; PubMed Central PMCID: PMC6200586.
Liu F, Tzeng WP, Horner L, Kamal RP, Tatum HR, Blanchard EG, Xu X, York I, Tumpey TM, Katz JM, Lu X, Levine MZ. Influence of Immune Priming and Egg Adaptation in the Vaccine on Antibody Responses to Circulating A(H1N1)pdm09 Viruses After Influenza Vaccination in Adults. J Infect Dis. 2018 Oct 5;218(10):1571-1581. doi: 10.1093/infdis/jiy376. PubMed PMID: 29931203; PubMed Central PMCID: PMC8974399.
Guo Z, Wilson JR, York IA, Stevens J. Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus. J Immunol Methods. 2018 Oct;461:23-29. doi: 10.1016/j.jim.2018.07.007. Epub 2018 Jul 24. Review. PubMed PMID: 30053389; PubMed Central PMCID: PMC6416777.
Sayedahmed EE, Hassan AO, Kumari R, Cao W, Gangappa S, York I, Sambhara S, Mittal SK. A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose. Mol Ther Methods Clin Dev. 2018 Sep 21;10:210-222. doi: 10.1016/j.omtm.2018.07.007. eCollection 2018 Sep 21. PubMed PMID: 30101154; PubMed Central PMCID: PMC6082999.
Alymova IV, McCullers JA, Kamal RP, Vogel P, Green AM, Gansebom S, York IA. Virulent PB1-F2 residues: effects on fitness of H1N1 influenza A virus in mice and changes during evolution of human influenza A viruses. Sci Rep. 2018 May 10;8(1):7474. doi: 10.1038/s41598-018-25707-y. PubMed PMID: 29749408; PubMed Central PMCID: PMC5945659.
Reber AJ, Music N, Kim JH, Gansebom S, Chen J, York I. Extensive T cell cross-reactivity between diverse seasonal influenza strains in the ferret model. Sci Rep. 2018 Apr 17;8(1):6112. doi: 10.1038/s41598-018-24394-z. PubMed PMID: 29666412; PubMed Central PMCID: PMC5904180.
Kamal RP, Alymova IV, York IA. Evolution and Virulence of Influenza A Virus Protein PB1-F2. Int J Mol Sci. 2017 Dec 29;19(1). doi: 10.3390/ijms19010096. Review. PubMed PMID: 29286299; PubMed Central PMCID: PMC5796046.
Wilson JR, Belser JA, DaSilva J, Guo Z, Sun X, Gansebom S, Bai Y, Stark TJ, Chang J, Carney P, Levine MZ, Barnes J, Stevens J, Maines TR, Tumpey TM, York IA. An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge. Virology. 2017 Nov;511:214-221. doi: 10.1016/j.virol.2017.08.016. Epub 2017 Sep 6. PubMed PMID: 28888111; PubMed Central PMCID: PMC5727915.
Kamal RP, Blanchfield K, Belser JA, Music N, Tzeng WP, Holiday C, Burroughs A, Sun X, Maines TR, Levine MZ, York IA. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies. J Virol. 2017 Oct 15;91(20). doi: 10.1128/JVI.01202-17. Print 2017 Oct 15. PubMed PMID: 28768855; PubMed Central PMCID: PMC5625511.
Hassan AO, Amen O, Sayedahmed EE, Vemula SV, Amoah S, York I, Gangappa S, Sambhara S, Mittal SK. Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses. PLoS One. 2017;12(10):e0186244. doi: 10.1371/journal.pone.0186244. eCollection 2017. PubMed PMID: 29023601; PubMed Central PMCID: PMC5638338.
Sun X, Belser JA, Pulit-Penaloza JA, Creager HM, Guo Z, Jefferson SN, Liu F, York IA, Stevens J, Maines TR, Jernigan DB, Katz JM, Levine MZ, Tumpey TM. Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade virus challenge in ferrets. Virology. 2017 Aug;508:164-169. doi: 10.1016/j.virol.2017.05.010. Epub 2017 May 26. PubMed PMID: 28554058; PubMed Central PMCID: PMC5788307.
Kumar A, Kim JH, Ranjan P, Metcalfe MG, Cao W, Mishina M, Gangappa S, Guo Z, Boyden ES, Zaki S, York I, García-Sastre A, Shaw M, Sambhara S. Influenza virus exploits tunneling nanotubes for cell-to-cell spread. Sci Rep. 2017 Jan 6;7:40360. doi: 10.1038/srep40360. PubMed PMID: 28059146; PubMed Central PMCID: PMC5216422.
Kim JH, Reber AJ, Kumar A, Ramos P, Sica G, Music N, Guo Z, Mishina M, Stevens J, York IA, Jacob J, Sambhara S. Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease. Sci Rep. 2016 Nov 16;6:37341. doi: 10.1038/srep37341. PubMed PMID: 27849030; PubMed Central PMCID: PMC5110975.
Wilson JR, Guo Z, Reber A, Kamal RP, Music N, Gansebom S, Bai Y, Levine M, Carney P, Tzeng WP, Stevens J, York IA. An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo. Antiviral Res. 2016 Nov;135:48-55. doi: 10.1016/j.antiviral.2016.10.001. Epub 2016 Oct 3. PubMed PMID: 27713074; PubMed Central PMCID: PMC5729279.
Alymova IV, York IA, Air GM, Cipollo JF, Gulati S, Baranovich T, Kumar A, Zeng H, Gansebom S, McCullers JA. Glycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulence. Sci Rep. 2016 Oct 31;6:36216. doi: 10.1038/srep36216. PubMed PMID: 27796371; PubMed Central PMCID: PMC5086918.
Music N, Reber AJ, Kim JH, York IA. Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus. PLoS One. 2016;11(6):e0157903. doi: 10.1371/journal.pone.0157903. eCollection 2016. PubMed PMID: 27315117; PubMed Central PMCID: PMC4912066.
Cao W, Liepkalns JS, Kamal RP, Reber AJ, Kim JH, Hofstetter AR, Amoah S, Stevens J, Ranjan P, Gangappa S, York IA, Sambhara S. RIG-I ligand enhances the immunogenicity of recombinant H7HA protein. Cell Immunol. 2016 Jun-Jul;304-305:55-8. doi: 10.1016/j.cellimm.2016.04.004. Epub 2016 Apr 9. PubMed PMID: 27106062; PubMed Central PMCID: PMC5240151.
Zhong W, Liu F, Wilson JR, Holiday C, Li ZN, Bai Y, Tzeng WP, Stevens J, York IA, Levine MZ. Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans. Open Forum Infect Dis. 2016 Apr;3(2):ofw102. doi: 10.1093/ofid/ofw102. eCollection 2016 Apr. PubMed PMID: 27419174; PubMed Central PMCID: PMC4943536.
Cao W, Liepkalns JS, Hassan AO, Kamal RP, Hofstetter AR, Amoah S, Kim JH, Reber AJ, Stevens J, Katz JM, Gangappa S, York IA, Mittal SK, Sambhara S. A highly immunogenic vaccine against A/H7N9 influenza virus. Vaccine. 2016 Feb 3;34(6):744-9. doi: 10.1016/j.vaccine.2015.12.062. Epub 2016 Jan 4. PubMed PMID: 26765287; PubMed Central PMCID: PMC4735641.
Music N, Reber AJ, Kim MC, York IA, Kang SM. Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets. Vaccine. 2016 Jan 20;34(4):466-473. doi: 10.1016/j.vaccine.2015.12.023. Epub 2015 Dec 19. PubMed PMID: 26709639; PubMed Central PMCID: PMC4713238.
Wilson JR, Guo Z, Tzeng WP, Garten RJ, Xiyan X, Blanchard EG, Blanchfield K, Stevens J, Katz JM, York IA. Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus. Virology. 2015 Nov;485:252-62. doi: 10.1016/j.virol.2015.08.004. Epub 2015 Aug 27. PubMed PMID: 26318247; PubMed Central PMCID: PMC5737639.
Kamal RP, Kumar A, Davis CT, Tzeng WP, Nguyen T, Donis RO, Katz JM, York IA. Emergence of Highly Pathogenic Avian Influenza A(H5N1) Virus PB1-F2 Variants and Their Virulence in BALB/c Mice. J Virol. 2015 Jun;89(11):5835-46. doi: 10.1128/JVI.03137-14. Epub 2015 Mar 18. PubMed PMID: 25787281; PubMed Central PMCID: PMC4442455.
Hearn C, Preeyanon L, Hunt HD, York IA. An MHC class I immune evasion gene of Marek׳s disease virus. Virology. 2015 Jan 15;475:88-95. doi: 10.1016/j.virol.2014.11.008. Epub 2014 Nov 27. PubMed PMID: 25462349; PubMed Central PMCID: PMC4280340.
Alymova IV, York IA, McCullers JA. Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers. PLoS One. 2014;9(11):e111603. doi: 10.1371/journal.pone.0111603. eCollection 2014. PubMed PMID: 25368997; PubMed Central PMCID: PMC4219726.
Blanchfield K, Kamal RP, Tzeng WP, Music N, Wilson JR, Stevens J, Lipatov AS, Katz JM, York IA. Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins. Influenza Other Respir Viruses. 2014 Nov;8(6):628-35. doi: 10.1111/irv.12285. Epub 2014 Sep 12. PubMed PMID: 25213778; PubMed Central PMCID: PMC4262278.
Music N, Reber AJ, Lipatov AS, Kamal RP, Blanchfield K, Wilson JR, Donis RO, Katz JM, York IA. Influenza vaccination accelerates recovery of ferrets from lymphopenia. PLoS One. 2014;9(6):e100926. doi: 10.1371/journal.pone.0100926. eCollection 2014. PubMed PMID: 24968319; PubMed Central PMCID: PMC4072694.
Wilson JR, Tzeng WP, Spesock A, Music N, Guo Z, Barrington R, Stevens J, Donis RO, Katz JM, York IA. Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin. Virology. 2014 Jun;458-459:114-24. doi: 10.1016/j.virol.2014.04.011. Epub 2014 May 10. PubMed PMID: 24928044; PubMed Central PMCID: PMC4904151.
Shepard SS, Davis CT, Bahl J, Rivailler P, York IA, Donis RO. LABEL: fast and accurate lineage assignment with assessment of H5N1 and H9N2 influenza A hemagglutinins. PLoS One. 2014;9(1):e86921. doi: 10.1371/journal.pone.0086921. eCollection 2014. PubMed PMID: 24466291; PubMed Central PMCID: PMC3900692.
Kamal RP, Katz JM, York IA. Molecular determinants of influenza virus pathogenesis in mice. Curr Top Microbiol Immunol. 2014;385:243-74. doi: 10.1007/82_2014_388. Review. PubMed PMID: 25038937; PubMed Central PMCID: PMC4618372.
Seregin SS, Rastall DP, Evnouchidou I, Aylsworth CF, Quiroga D, Kamal RP, Godbehere-Roosa S, Blum CF, York IA, Stratikos E, Amalfitano A. Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens. Autoimmunity. 2013 Dec;46(8):497-508. doi: 10.3109/08916934.2013.819855. Epub 2013 Sep 13. PubMed PMID: 24028501; PubMed Central PMCID: PMC4104477.
York I, Donis RO. The 2009 pandemic influenza virus: where did it come from, where is it now, and where is it going?. Curr Top Microbiol Immunol. 2013;370:241-57. doi: 10.1007/82_2012_221. Review. PubMed PMID: 22638836.
Nguyen T, Rivailler P, Davis CT, Hoa do T, Balish A, Dang NH, Jones J, Vui DT, Simpson N, Huong NT, Shu B, Loughlin R, Ferdinand K, Lindstrom SE, York IA, Klimov A, Donis RO. Evolution of highly pathogenic avian influenza (H5N1) virus populations in Vietnam between 2007 and 2010. Virology. 2012 Oct 25;432(2):405-16. doi: 10.1016/j.virol.2012.06.021. Epub 2012 Jul 20. PubMed PMID: 22818871.
Tong S, Li Y, Rivailler P, Conrardy C, Castillo DA, Chen LM, Recuenco S, Ellison JA, Davis CT, York IA, Turmelle AS, Moran D, Rogers S, Shi M, Tao Y, Weil MR, Tang K, Rowe LA, Sammons S, Xu X, Frace M, Lindblade KA, Cox NJ, Anderson LJ, Rupprecht CE, Donis RO. A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4269-74. doi: 10.1073/pnas.1116200109. Epub 2012 Feb 27. PubMed PMID: 22371588; PubMed Central PMCID: PMC3306675.
Kincaid EZ, Che JW, York I, Escobar H, Reyes-Vargas E, Delgado JC, Welsh RM, Karow ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Rock KL. Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat Immunol. 2011 Dec 25;13(2):129-35. doi: 10.1038/ni.2203. PubMed PMID: 22197977; PubMed Central PMCID: PMC3262888.
Hossain MJ, Bourgeois M, Quan FS, Lipatov AS, Song JM, Chen LM, Compans RW, York I, Kang SM, Donis RO. Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza. Clin Vaccine Immunol. 2011 Dec;18(12):2010-7. doi: 10.1128/CVI.05206-11. Epub 2011 Oct 26. PubMed PMID: 22030367; PubMed Central PMCID: PMC3232700.
Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, Davidson DJ, Donis RO. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One. 2011;6(10):e25333. doi: 10.1371/journal.pone.0025333. Epub 2011 Oct 21. PubMed PMID: 22031815; PubMed Central PMCID: PMC3198734.
Spesock A, Malur M, Hossain MJ, Chen LM, Njaa BL, Davis CT, Lipatov AS, York IA, Krug RM, Donis RO. The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins. J Virol. 2011 Jul;85(14):7048-58. doi: 10.1128/JVI.00417-11. Epub 2011 May 18. PubMed PMID: 21593152; PubMed Central PMCID: PMC3126612.
Nguyen TT, Chang SC, Evnouchidou I, York IA, Zikos C, Rock KL, Goldberg AL, Stratikos E, Stern LJ. Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nat Struct Mol Biol. 2011 May;18(5):604-13. doi: 10.1038/nsmb.2021. Epub 2011 Apr 10. PubMed PMID: 21478864; PubMed Central PMCID: PMC3087843.
Evnouchidou I, Kamal RP, Seregin SS, Goto Y, Tsujimoto M, Hattori A, Voulgari PV, Drosos AA, Amalfitano A, York IA, Stratikos E. Cutting Edge: Coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme. J Immunol. 2011 Feb 15;186(4):1909-13. doi: 10.4049/jimmunol.1003337. Epub 2011 Jan 17. PubMed PMID: 21242517; PubMed Central PMCID: PMC4039038.
Dang Y, Wang X, York IA, Zheng YH. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity. J Virol. 2010 Sep;84(17):8561-70. doi: 10.1128/JVI.00960-10. Epub 2010 Jun 30. PubMed PMID: 20592083; PubMed Central PMCID: PMC2919012.
Georgiadou D, Hearn A, Evnouchidou I, Chroni A, Leondiadis L, York IA, Rock KL, Stratikos E. Placental leucine aminopeptidase efficiently generates mature antigenic peptides in vitro but in patterns distinct from endoplasmic reticulum aminopeptidase 1. J Immunol. 2010 Aug 1;185(3):1584-92. doi: 10.4049/jimmunol.0902502. Epub 2010 Jun 30. PubMed PMID: 20592285; PubMed Central PMCID: PMC2910840.
Dang Y, Davis RW, York IA, Zheng YH. Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity. J Virol. 2010 Jun;84(11):5741-50. doi: 10.1128/JVI.00079-10. Epub 2010 Mar 24. PubMed PMID: 20335268; PubMed Central PMCID: PMC2876610.
Hearn A, York IA, Bishop C, Rock KL. Characterizing the specificity and cooperation of aminopeptidases in the cytosol and endoplasmic reticulum during MHC class I antigen presentation. J Immunol. 2010 May 1;184(9):4725-32. doi: 10.4049/jimmunol.0903125. Epub 2010 Mar 29. PubMed PMID: 20351195; PubMed Central PMCID: PMC2858786.
Kawahara M, York IA, Hearn A, Farfan D, Rock KL. Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo. J Immunol. 2009 Nov 15;183(10):6069-77. doi: 10.4049/jimmunol.0803564. Epub 2009 Oct 19. PubMed PMID: 19841172; PubMed Central PMCID: PMC4314709.
What would you like to do?